By Pam Brown, GP and Editor-in-Chief of Diabetes & Primary Care
These investigators developed models that help to quantify the risk of progression of non-diabetic hyperglycaemia to type 2 diabetes, as well as the likelihood of regression to normal glucose levels. These models allow prediction of an individual’s absolute risk reduction of progression or regression with lifestyle or drug therapy, allowing those with impaired glucose regulation to more clearly understand their risks and the likely benefits from therapy options. This takes us one step closer to being able to individualise diabetes prevention
To access the article, click here (log in or purchase required).
